Mühl, Diana <br/><br/>
[Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].  [electronic resource] 

 -  Orvosi hetilap  May 2008 
 - 935-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0030-6002 
<br/><br/><label>Standard No.: </label>10.1556/OH.2008.28356  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antigens, CD--blood<br/>Biomarkers--blood<br/>CD11a Antigen--blood<br/>CD18 Antigens--blood<br/>Female<br/>Fibrin Fibrinogen Degradation Products--metabolism<br/>Fibrinogen--metabolism<br/>Glutathione--blood<br/>Hemoglobins--metabolism<br/>Hemostasis--drug effects<br/>Humans<br/>Leukocytes--drug effects<br/>Male<br/>Malondialdehyde--blood<br/>Membrane Glycoproteins--blood<br/>Middle Aged<br/>Oxidative Stress--drug effects<br/>Patient Selection<br/>Peroxidase--blood<br/>Platelet Aggregation--drug effects<br/>Pulmonary Embolism--blood<br/>Reactive Oxygen Species--blood<br/>Receptors, G-Protein-Coupled<br/>Streptokinase--administration & dosage<br/>Superoxide Dismutase--blood<br/>Thrombolytic Therapy--methods<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage